Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	80,949
Curr. Assets	:	167,508
Fixed Assets	:	1,392
Total Assets	:	168,900
Curr. Liabilities	:	3,931
Long Term Debt	:	0
Minority Interest	:	0
Total Liabilities	:	3,931
Paid-Up Capital	:	1,300
Total Equity	:	164,969
Income Statement
Total Sales	:	5,652
Gross Profit	:	5,652
Operating Profit	:	3,860
Net Income	:	3,635
Cash Flow Statement
Cash From Operating Act	:	-43,082
Cash From Investing Act	:	0
Cash From Financing Act	:	-148
Per Share Data (in IDR)
EPS	:	2.80
Book Value	:	126.90
Financial Ratios
Der	:	0.02
Roa	:	2.57
Roe	:	0.09
Npm	:	0.64
Opm	:	0.68
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	Perajin tempe di Ponorogo siasati ukuran imbas kenaikan harga kedelai

2	OPAQUE Akuisisi Teknologi AI Kriptografi Abu Dhabi Dari TII

3	TIME Nobatkan Xenco Medical sebagai Salah Satu dari TIME100 Most Influential Companies in the World

4	Canton Fair Ke-139: Pertumbuhan "Sleep Economy" Dorong Inovasi "Home Textile"

5	Brookfield dan The Nuclear Company Bermitra Untuk Mendirikan Perusahaan Baru Guna Mempercepat Pengembangan Nuklir di A.S

Perajin tempe di Ponorogo siasati ukuran imbas kenaikan harga kedelai